Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04549571 · ClinicalTrials.gov registry record · NA
Improving Patient-Centered Communication in Breast Cancer Through Patient and Provider Interventions
A NA study of Anatomic Stage III Breast Cancer AJCC v8 and Anatomic Stage II Breast Cancer AJCC v8, sponsored by Alliance for Clinical Trials in Oncology.
- Active
- Registry status
- NA
- Development phase
- 543
- Enrollment target
- 20
- Study locations
NCT04549571: Active NA study of Anatomic Stage III Breast Cancer AJCC v8 and Anatomic Stage II Breast Cancer AJCC v8, sponsored by Alliance for Clinical Trials in Oncology.
NCT04549571 is a NA study of Anatomic Stage III Breast Cancer AJCC v8 and Anatomic Stage II Breast Cancer AJCC v8 that is active but no longer recruiting, run by Alliance for Clinical Trials in Oncology. The registered enrollment target is 543 participants, above the 298-participant average among 84 other Anatomic Stage III Breast Cancer AJCC v8 trials with a reported enrollment target (82% higher). The trial reports 20 study locations across 12 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04549571, a NA study of Anatomic Stage III Breast Cancer AJCC v8 and Anatomic Stage II Breast Cancer AJCC v8, is active but no longer recruiting, sponsored by Alliance for Clinical Trials in Oncology.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 543 participants
- Enrollment target
- 20
- Study locations
Study Summary
This trial studies the effectiveness of two interventions on patient reported outcomes of patient centered communication and decision making about breast cancer treatment. The first intervention consists of enhancements to an existing patient-facing breast cancer treatment decision tool called iCanDecide that supports the management of worry, distress, and anxiety as compared to an existing tool. The second intervention consists of a clinician dashboard that populates information after patients view either website regarding any ongoing issues or concerns.
Primary Outcome
Will be defined as the percentage of correct answers (range: 0-100%) from a 5-item scale previously developed and pilot tested where higher percentages indicate increased knowledge of treatment risks and benefits of local regional treatment. Because the interventions are fully crossed (with intervention and control patients within both intervention and control practices for every time period), the intervention effect of iCanDecide-E and the intervention effect of the clinician dashboard (CDB) wi
Conditions Studied
Interventions
- PROCEDURE Therapeutic Conventional Surgery
- OTHER Interview
- OTHER Training
- OTHER Decision Aid iCanDecide - ESE website
- OTHER Decision Aid iCanDecide - S website
Study Locations (20)
Michigan
- Corewell Health Grand Rapids Hospitals - Butterworth Hospital - Grand Rapids
- West Michigan Cancer Center - Kalamazoo
- Ascension Borgess Hospital - Kalamazoo
New York
- Northern Westchester Hospital - Mount Kisco
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center - New York
- Montefiore Medical Center-Einstein Campus - The Bronx
Ohio
- Adena Regional Medical Center - Chillicothe
- Saint Ann's Hospital - Westerville
- Genesis Healthcare System Cancer Care Center - Zanesville
Delaware
- Helen F Graham Cancer Center - Newark
- Beebe Health Campus - Rehoboth Beach
North Dakota
- Sanford Bismarck Medical Center - Bismarck
- Sanford Broadway Medical Center - Fargo
California
- Kaiser Permanente-Vallejo - Vallejo
Georgia
- Lewis Cancer and Research Pavilion at Saint Joseph's/Candler - Savannah
Hawaii
- Kaiser Permanente Moanalua Medical Center - Honolulu
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 543 participants |
| Start Date | 2021-02-16 |
| Est. Completion | 2027-01 |
| Phase | NA |
What the registry record for NCT04549571 still lists
NCT04549571 is an interventional study that assigns participants to a tested intervention. The registered 543 participants enrollment target is mid-sized for trials with a published cap, above the 298-participant average among 84 other Anatomic Stage III Breast Cancer AJCC v8 trials with a reported enrollment target (82% higher).
The record links to 10 conditions, with Anatomic Stage III Breast Cancer AJCC v8 appearing as the primary indexed condition, and to 5 interventions - of which Therapeutic Conventional Surgery is the first listed.
NCT04549571 names 20 study sites across 12 states, led by Michigan, New York, Ohio.
Frequently Asked Questions
What is clinical trial NCT04549571 about?
NCT04549571 is a clinical study titled "Improving Patient-Centered Communication in Breast Cancer Through Patient and Provider Interventions". This trial studies the effectiveness of two interventions on patient reported outcomes of patient centered communication and decision making about breast cancer treatment. The first intervention consists of enhancements to an existing patient-facing breast cancer treatment decision tool called iCanD...
What is the current status of trial NCT04549571?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 543 participants. The study started on 2021-02-16. Estimated completion is 2027-01.
What conditions does trial NCT04549571 study?
This clinical trial studies the following conditions: Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIA Breast Cancer AJCC v8.
What interventions are being tested in trial NCT04549571?
The interventions under investigation include: Therapeutic Conventional Surgery (PROCEDURE), Interview (OTHER), Training (OTHER), Decision Aid iCanDecide - ESE website (OTHER), Decision Aid iCanDecide - S website (OTHER).
Who is sponsoring clinical trial NCT04549571?
This trial is sponsored by Alliance for Clinical Trials in Oncology, which has 446 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04549571 being conducted?
This trial has 20 study locations across California, Delaware, Georgia, Hawaii, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anatomic Stage III Breast Cancer AJCC v8
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04549571's enrollment target sits among peer trials
543 14th of 84 higher than 71 of 84 other Anatomic Stage III Breast Cancer AJCC v8 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Anatomic Stage III Breast Cancer AJCC v8 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Lymphovenous Bypass Procedure Before Underarm Lymph Node Surgery in Preventing Lymphedema in Patients With Inflammatory or Locally Advanced Non-inflammatory Breast Cancer or Melanoma
RECRUITING · NA
-
A Quality of Life Intervention for Young African American Breast Cancer Survivors in Treatment
RECRUITING · NA
-
Food for Thought - A Nutrition Intervention for Women Undergoing Active Treatment for Triple Negative Breast Cancer
RECRUITING · NA
-
Transcutaneous Electrical Nerve Stimulation in Chemotherapy Induced Peripheral Neuropathy in Patients With Stage I-III Early Stage Breast Cancer
RECRUITING · NA
-
Remotely Delivered, Community-Aligned Weight Loss Interventions Among Breast Cancer Survivors, ¡Vida! Trial
RECRUITING · NA
-
Feasibility Study of Biobehavioral Stress Reduction Intervention in Patients With Triple Negative Breast Cancer
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07294053 · 543 participants · NA
Sugary Drink Labeling Study
- NCT03127761 · 544 participants
Assessment of Allogeneic Hematopoietic Cell Transplantation in Medicare Beneficiaries With Multiple Myeloma
- NCT04378790 · 544 participants · Phase 3
A Randomized Trial to Evaluate Sequential vs Simultaneous Patching
- NCT06118502 · 544 participants · NA
A Clinical Trial of Adaptive Treatment for Early Smoking Cessation Relapse
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI